Cyplasin Biomedical Ltd. announced today that it has entered into an irrevocable Letter of Intent (LOI) with Arizona -based Virionics Corporation, to effect a reverse take over of 100% of the Company.
For more information: Cyplasin Biomedical Ltd., and Virionics Corporation, announces Letter of Intent (LOI) for Reverse Takeover (RTO), Name Change and Related Financings